Medevise Consulting to Host “Robotics in Ophthalmology” Workshop in New Orleans During AAO 2026

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Medevise Consulting to Host "Robotics in Ophthalmology" Workshop in New Orleans During AAO 2026Author of the article:A panel of regulatory, reimbursement and industry expert will gather to discuss surgical robotics in ophthalmology. GNWRegulatory, reimbursement, and surgical robotics leaders will ask what it takes for robots to leapfrog today’s standard of care in eye surgeryTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountNEW ORLEANS, Sept. 24, 2026 (GLOBE NEWSWIRE) — Medevise Consulting today announced “Robotics in Ophthalmology: What it takes to create a game changing technology”. It will take place on Thursday, 8 October 2026, from 5:30 to 7:30 PM in New Orleans, as the American Academy of Ophthalmology (AAO) annual meeting weekend begins.Ophthalmologists have been experimenting with robotic assistance in eye surgery for more than a decade. Early milestones include the adaptation of a da Vinci system for corneal transplantation and the first intraocular procedures in humans performed using the Preceyes robot. Today, at least six companies are developing ophthalmic surgical robots, including Horizon Surgical Systems with its Polaris Platform. The workshop will address the central questions facing the field: can these technologies leapfrog the current standard of care? And what will it take to get there, given that other approaches have failed to replace established systems?Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againRegulatory and reimbursement in the spotlightThe evening will end with a “Reality Check” session on the hurdles every surgical robot must clear before it reaches patients.Malvina Eydelman, MD, CEO of Salution Nexus and former Director of the FDA’s Office of Health Technology, Ophthalmic, Anesthesia, Respiratory, ENT, & Dental Devices, will explain how the FDA views robotics.Kevin J. Corcoran, Principal of Corcoran Consulting Group and a leading authority on ophthalmic coding and reimbursement, will map out the reimbursement landscape for surgical robots.Marc de Smet, MD, PhD, Founder of MicroInvasive Ocular Surgery Center (MIOS) and a pioneer of robot-assisted intraocular surgery, will speak in the opening section. His talk titled “Lessons learned and where do we go from here?” draws on his role in the first robotic eye surgery study in humans.Welcome and introduction of faculty: Kristine Morrill, President, Medevise Consulting (Moderator)Where we are today and what are the challenges ahead?: JP Hubschman, MD, CEO, Horizon Surgical SystemsLessons learned and where do we go from here?: Marc de Smet, MD, PhD, Founder, MIOSHow do we make surgical robots agile and adaptable?: Ben Ko, CEO, Kaleidoscope InnovationVisionary thinking: Are micro-robots the game changing technology?: Remy Tribhout, CEO, PhigiThe role of 4D/AI imaging in robotic surgical planning: Luc Soler, CEO, Visible PatientHow virtual reality training software can advance robotics outcomes: Pierre-Jean Bensoussan, CEO, InSimo (developer of the HelpMeSee simulator)Section 3: Reality Check, Regulatory and ReimbursementHow does the FDA view robotics?: Malvina Eydelman, MD, CEO, Salution NexusThe EU regulatory view: Kristine Morrill, Medevise ConsultingThe reimbursement landscape for surgical robots: Kevin J. Corcoran, Principal, Corcoran Consulting GroupThis advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.Each section ends with a moderated discussion, and the evening closes with a panel discussion that will include audience participation. “Robotics has the potential to change how we operate on the eye, but good engineering alone won’t get it into the operating room. This workshop brings together the people building these systems and the people who decide whether they reach patients: regulators, reimbursement experts, and innovators. We want an honest conversation about what it will really take,” said Kristine Morrill, President of Medevise Consulting.The workshop is aimed at ophthalmic surgeons, industry executives, investors, and innovators working in surgical robotics and advanced ophthalmic technologies. It will be held at the Embassy Suites New Orleans. Details and registration are available at www.medevise-events.com.About Medevise ConsultingMedevise Consulting brings medical innovations to life. Based in Strasbourg, France, on the NextMed medical technology innovation campus, Medevise works with medical device and pharmaceutical companies from idea to adoption, with a particular focus on ophthalmology. The firm combines clinical, regulatory and marketing expertise to build strategies that win the trust of regulators, clinicians and payers alike.The firm also hosts the podcast Oracles of Eye Innovation.Lauren RedmondMedevise Consultinglauren@medevise-consulting.comNotice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.